Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf075 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Peter Sabatini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, DNA Methylation, Polymerase Chain Reaction, Immunoglobulin Heavy Chains. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: University Health Network Laboratory Medicine Program.
Abstract (Originalsprache)
Objective
Somatic hypermutation at immunoglobulin heavy chain variable (IGHV) genes, an established prognostic and predictive biomarker for chronic lymphocytic leukemia (CLL), is assessed by gene sequencing. We developed a single methylation-specific droplet digital polymerase chain reaction (methyl-ddPCR) to predict IGHV status in patients with CLL.
Methods
The CLL methylation array and IGHV data from the International Cancer Genome Consortium (ICGC) were used for biomarker discovery. Top-ranked candidate regions were manually screened for PCR primer and probe binding sites. A single methyl-ddPCR was evaluated on an internal cohort of CLLs with mutated (M), unmutated (U), and inconclusive IGHV results originally determined by next-generation sequencing (NGS).
Results
Analysis of ICGC data identified array probe cg23844018 as a candidate for the PCR. The corresponding CpG site showed high methylation levels in U-CLL and lower levels in M-CLL. On the internal cohort, a single optimal cutoff correctly classified 104 of 115 U- and M-CLLs (90.4%; area under the curve = 0.96). The PCR data correlated with some prognostic fluorescence in situ hybridization and CLL subset groupings. Limited analysis suggests that the PCR may be able to stratify some patients with CLL who have inconclusive results on IGHV NGS testing.
Conclusions
The methyl-ddPCR showed high concordance with CLL IGHV status in an internal cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Genome Diagnostics, University Health Network, Toronto, Ontario, Canada.
- Advanced Molecular Diagnostics Laboratory, University Health Network, Toronto, Ontario, Canada.
- Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Division of Hematopathology and Transfusion Medicine, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Daniel Xia
Förderung
- University Health Network Laboratory Medicine Program
Zitieren
APA
Sabatini, P., Zhang, T., Boruvka, N., Kim, H. S., Feilotter, H., Stockley, T., Chen, C., & Xia, D. (2025). Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf075
Vancouver
Sabatini P, Zhang T, Boruvka N, Kim HS, Feilotter H, Stockley T, et al. Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf075
BibTeX
@article{Sabatini2025,
author = {Sabatini, Peter and Zhang, Tong and Boruvka, Natalie and Kim, Hyun Sean and Feilotter, Harriet and Stockley, Tracy and Chen, Christine and Xia, Daniel},
title = {Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf075}
}
EUVIMED